United States Ex Rel. Booker v. Pfizer, Inc.
Court of Appeals for the First Circuit
1Opinion of the Court
LYNCH, Circuit Judge.
On August 31, 2009, the pharmaceutical company Pfizer, Inc. settled various claims that it had violated the False Claims Act (“FCA”), 31 U.S.C. §§ 3729 et seq„ with the U.S. Department of Justice (“DOJ”). As part of that settlement, Pfizer entered into a Corporate Integrity Agreement (“CIA”) with the U.S. Department of Health and Human Services (“HHS”).
Less than a year after that settlement, relators Alex Booker and Edmund He-bron, two former Pfizer sales representatives, brought this qui tam action against Pfizer in federal district court, alleging it was on behalf of…
2Cases cited27 opinions
- Goodman v. National Security Agency, Inc.Court of Appeals for the Seventh Circuit · 2010
- Allison Engine Co. v. United States Ex Rel. SandersSupreme Court of the United States · 2008
- United States Ex Rel. Karvelas v. Melrose-Wakefield HospitalCourt of Appeals for the First Circuit · 2004
- United States Ex Rel. Yesudian v. Howard UniversityCourt of Appeals for the D.C. Circuit · 1998
- Feliciano De La Cruz v. El Conquistador Resort & Country ClubCourt of Appeals for the First Circuit · 2000
22 more not listed; retrieve them via the Exa API.
3Cited by53 opinions
- United States ex rel. Grant v. United Airlines Inc.Court of Appeals for the Fourth Circuit · 2018
- Guilfoile v. ShieldsCourt of Appeals for the First Circuit · 2019
- United States of America ex v. Keypoint Government SolutionsCourt of Appeals for the Tenth Circuit · 2019
- United States Ex Rel. Greenfield v. Medco Health Solutions, Inc.Court of Appeals for the Third Circuit · 2018
- United States v. Solvay Pharmaceuticals, Inc.Court of Appeals for the Fifth Circuit · 2017
48 more not listed; retrieve them via the Exa API.